… In pulmonary fibroblasts from patients with SSc, 5-aza treatment restored PTGS2 and
prostaglandin E 2 production, and in TGFβ-stimulated pulmonary fibroblasts from mice, it …

Objective MicroRNAs (miRNAs) are regulatory molecules, which have been addressed as
potential biomarkers and therapeutic targets in rheumatic diseases. Here, we investigated the …

… E and F, Percentage of PDCs circulating in the peripheral blood of healthy controls (HC)
and systemic sclerosis (SSc) patients as a whole (E) and in the peripheral blood of healthy …

… a b c , Floor de Wit a , Marta Cossu a b , Eleni Chouri a b , Catharina GK Wichers a b , Cornelis
PJ … 4E) were obtained using Crenolanib, a small molecule inhibitor of the PDGF receptor. …

… (E) Correlation between the expression of MX1 with STAT1 and STAT2 in the discovery
cohort based on RNAseq data (left panels) and the validation cohort according to qPCR analysis …

… Populations in red are not significantly altered in patients not treated with prednisone as
compared with HC E) Decrease in plasmacytoid dendritic cells is also present in patients not …

… e) Venn diagram showing the exact number of persistent and non-persistent TCR … 2e.
Although the absolute number of sequences that are overlapping within patients over time (ie …

… (E) Absolute … (E) Corresponding dot plot of biological replicate of cells activated with R848
for 2h, treated with 10 uM JAKi. (F) Corresponding dot plot of biological replicate as in (E), …

… (E) Box plot depicting droplet volumes in pL, n = 100 droplets. (F) Theoretical fractions of
total droplets (left) and cell-containing droplets (right) with x number of cells per droplet, …

Systemic sclerosis (SSc) is a rare chronic disease of unknown pathogenesis characterized
by fibrosis of the skin and internal organs, vascular alteration, and dysregulation of the …